TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34133831

Group type: EXPERIMENTAL
Intervention: Rhomboid intercostal nerve block (RIB)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Serratus plane block (SAB)
Number of subjects: 90
Study: 32413540

Group type: COMPARATOR
Intervention: Paired-pulse Transcranial Magnetic Stimulation (ppTMS) delivered at 120% resting motor threshold (RMT) at two locations: 3 cm dorsal and 5 cm lateral to inion, or at the site of peak activation for motion according to NeuroSynth fMRI database.
Number of subjects: 15
Study: 35979845

Group type: EXPERIMENTAL
Intervention: Ecologically relevant neuropsychological battery (Six Elements, Zoo Map, Hayling Sentence Completion, Iowa Gambling, Auditory Startle Tasks)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Traditional EF tasks (Card Sorting, Trail Making, Color-Word Interference, Verbal Fluency)
Number of subjects: 59
Study: 33830025

Group type: EXPERIMENTAL
Intervention: Tacrolimus and Mycophenolate Mofetil (MMF) for GVHD prophylaxis
Number of subjects: 150
Study: 32649856

Group type: EXPERIMENTAL
Intervention: Thrombin-induced platelet aggregation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GRK5 variant (rs10886430-G)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analyses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: G protein-coupled receptor kinase 5 (GRK5)
Number of subjects: 0
Study: 35427476

Group type: EXPERIMENTAL
Intervention: DC371739
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DC371739 + Atorvastatin
Number of subjects: 0
Study: 32709507

Group type: EXPERIMENTAL
Intervention: Inhalation of 4 drops of 2% lavender essential oil with oxygen for 20 minutes
Number of subjects: 90

Group type: COMPARATOR
Intervention: Inhalation of oxygen only
Number of subjects: 90
Study: 35042472

Group type: EXPERIMENTAL
Intervention: Allergic asthma
Number of subjects: 1506

Group type: COMPARATOR
Intervention: Non-allergic asthma
Number of subjects: 1506

Group type: COMPARATOR
Intervention: Inhalative allergy
Number of subjects: 1506
Study: 34508693

Group type: EXPERIMENTAL
Intervention: Losmapimod
Number of subjects: 3489

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3489
Study: 33067319

Group type: EXPERIMENTAL
Intervention: Axitinib (5 mg oral two times per day) plus avelumab (10 mg/kg intravenous every 2 weeks) in Cohort-1
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Axitinib monotherapy in Cohort-2 (avelumab added after 6 weeks if corticosteroid dose could be tapered to ≤8 mg)
Number of subjects: 54
Study: 35394525

Group type: EXPERIMENTAL
Intervention: Positive STEPS intervention (community health worker-led, 7-week duration, weekly telephone sessions, web-based videos, positive activities, wearable activity trackers)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Positive STEPS intervention
Number of subjects: 46
Study: 33760027

Group type: EXPERIMENTAL
Intervention: edoxaban (oral factor Xa inhibitor)
Number of subjects: 6308
Study: 32792320

Group type: EXPERIMENTAL
Intervention: L-thyroxine (n = 40)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (n = 20)
Number of subjects: 60
Study: 36357636

Group type: EXPERIMENTAL
Intervention: Skeletal muscle ultrasound assessment (QRFT and QVIT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dietary intake assessment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Skeletal muscle ultrasound assessment (QRFT)
Number of subjects: 40
Study: 33906695

Group type: EXPERIMENTAL
Intervention: Thermal gun
Number of subjects: 76

Group type: COMPARATOR
Intervention: Heat pack
Number of subjects: 76
Study: 37244809

Group type: EXPERIMENTAL
Intervention: Coadministration of PCV20 and BNT162b2
Number of subjects: 570

Group type: COMPARATOR
Intervention: PCV20 only
Number of subjects: 570

Group type: COMPARATOR
Intervention: BNT162b2 only
Number of subjects: 570
Study: 34197133

Group type: EXPERIMENTAL
Intervention: Go/No-Go training (HitnRun)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Psychoeducational brochure (Control)
Number of subjects: 106
Study: 32311555

Group type: EXPERIMENTAL
Intervention: Low-Molecular-Weight Heparin (LMWH) for 14 days in patients older than 70 years
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Low-Molecular-Weight Heparin (LMWH) in patients younger than 70 years
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Enoxaparin and danaparoid
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 19
Study: 35961517

Group type: EXPERIMENTAL
Intervention: High-dose autologous skeletal muscle-derived cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose autologous skeletal muscle-derived cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cell-free medium (Control)
Number of subjects: 0
Study: 33468112

Group type: EXPERIMENTAL
Intervention: National salt iodization program
Number of subjects: 408
Study: 32408245

Group type: EXPERIMENTAL
Intervention: Three-phase video-assisted debriefing (VAD)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Verbal debriefing (VD)
Number of subjects: 145
Study: 35930287

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 400

Group type: COMPARATOR
Intervention: NRT
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Cytisine
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Behavior change (post hoc analysis)
Number of subjects: 400
Study: 32171637

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids intervention (specific dosage and duration not mentioned)
Number of subjects: 207
Study: 35261299

Group type: EXPERIMENTAL
Intervention: Drospirenone (DRSP) 4 mg
Number of subjects: 249

Group type: COMPARATOR
Intervention: Desogestrel (DSG) 0.075 mg
Number of subjects: 249
Study: 33407051

Group type: EXPERIMENTAL
Intervention: Water Immersion (WI) - 30 minutes standing immobile in a swimming pool
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Water Immersion (WI) - 30 minutes walking in the pool
Number of subjects: 14

Group type: COMPARATOR
Intervention: Walking on ground - 30 minutes
Number of subjects: 14
Study: 33253306

Group type: EXPERIMENTAL
Intervention: Local Anesthesia (LA)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Spinal Anesthesia (SA)
Number of subjects: 54

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 54
Study: 34269455

Group type: EXPERIMENTAL
Intervention: 450-ml blood donation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (no blood donation)
Number of subjects: 14
Study: 36418502

Group type: EXPERIMENTAL
Intervention: Experimental desensitizing gel (10% calcium gluconate, 0.1% dexamethasone acetate, 10% potassium nitrate, 5% glutaraldehyde) applied for 10 min before bleaching.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo gel applied for 10 min before bleaching.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups underwent in-office bleaching with 35% hydrogen peroxide for 50 min, two sessions, 1-week interval.
Number of subjects: 50
Study: 34189760

Group type: EXPERIMENTAL
Intervention: 55% of 1RM (MSR group)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 90% of 1RM (HSR group)
Number of subjects: 44
Study: 32347977

Group type: EXPERIMENTAL
Intervention: Oral melatonin 3 mg/d (immediate-release) at bedtime
Number of subjects: 4499

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4499
Study: 35315918

Group type: EXPERIMENTAL
Intervention: Stage 1 (130 patients)
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Stage 2 (578 patients)
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Stage 3 (530 patients)
Number of subjects: 1238
Study: 34682623

Group type: EXPERIMENTAL
Intervention: Menthol smoking
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Socioeconomic deprivation
Number of subjects: 146
Study: 32394466

Group type: EXPERIMENTAL
Intervention: St(a+) with trypsin-resistant 'N' antigen
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Sequencing of St(a+) individuals
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: St(a+) with trypsin-resistant M antigen
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: GYP(A-ψB-A) hybrid allele
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Novel GYP(A-ψB-A) allele
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Novel GYP(A-E-A) allele
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Novel GYP(A-A) allele
Number of subjects: 1001
Study: 35614395

Group type: EXPERIMENTAL
Intervention: Goal-Directed Fluid Therapy (GDFT)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Liberal Fluid Infusion (LFI)
Number of subjects: 58
Study: 34516692

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine plus 2 grams of Docosahexaenoic acid (DHA) + Eicosapentaenoic acid (EPA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hydroxychloroquine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine plus 2 grams of DHA + EPA
Number of subjects: 30
Study: 33177323

Group type: EXPERIMENTAL
Intervention: Rifampin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 36180962

Group type: EXPERIMENTAL
Intervention: Blended therapy with therapeutic online intervention (TONI) containing 12 transdiagnostic online modules
Number of subjects: 1152

Group type: COMPARATOR
Intervention: Face-to-face therapy
Number of subjects: 1152

Group type: EXPERIMENTAL
Intervention: Blended therapy
Number of subjects: 1152
Study: 34003937

Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Laser
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Observation
Number of subjects: 387
Study: 35114141

Group type: EXPERIMENTAL
Intervention: Concomitant administration of QIV-HD and mRNA-1273 vaccine
Number of subjects: 306

Group type: COMPARATOR
Intervention: QIV-HD alone
Number of subjects: 306

Group type: COMPARATOR
Intervention: mRNA-1273 vaccine alone
Number of subjects: 306
Study: 34554717

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 122

Group type: COMPARATOR
Intervention: Non-surgical treatment
Number of subjects: 122
Study: 32228743

Group type: COMPARATOR
Intervention: Control diet with no additive (CON)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Control diet with 0.5 g/day of SDR (SDR0.5)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Control diet with 1 g/day of SDR (SDR1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Control diet with 1.5 g/day of SDR (SDR1.5)
Number of subjects: 40
Study: 35652829

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ) ingestion (140 mL, ∼12.8 mmol of nitrate)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PL) ingestion (140 mL)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ) ingestion
Number of subjects: 11
Study: 32453643

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Microdebrider-assisted inferior turbinoplasty (MAIT)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 32908173

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 88
Study: 35198533

Group type: EXPERIMENTAL
Intervention: Back propagate neural network
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Linear regression
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both acceleration and heart rate
Number of subjects: 45

Group type: COMPARATOR
Intervention: Back propagate neural network vs Linear regression
Number of subjects: 45
Study: 36094222

Group type: EXPERIMENTAL
Intervention: T-Scan™ guided stabilization splint (SS)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Stabilization splint (SS)
Number of subjects: 48
Study: 32833791

Group type: EXPERIMENTAL
Intervention: Prism adaptation treatment (n = 23)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Sham treatment (n = 26)
Number of subjects: 49
Study: 34033237

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lacosamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35312137

Group type: EXPERIMENTAL
Intervention: Meditation-Based Lifestyle Modification (MBLM)
Number of subjects: 81

Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 81

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 81
Study: 32277253

Group type: EXPERIMENTAL
Intervention: Thrombocytosis (platelet count ≥ 400⋅10^9/L)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Normal platelet count
Number of subjects: 300
Study: 34102137

Group type: EXPERIMENTAL
Intervention: Nivolumab plus chemotherapy
Number of subjects: 1581

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 1581
Study: 33223831

Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus rhamnosus GG)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 33720917

Group type: EXPERIMENTAL
Intervention: Surgical taping
Number of subjects: 40

Group type: COMPARATOR
Intervention: External splints
Number of subjects: 40
Study: 32243403

Group type: EXPERIMENTAL
Intervention: Evaluation of ultrasound images without bony roof and cartilage roof measurements by orthopedic surgery residents, specialists, and professors.
Number of subjects: 210

Group type: COMPARATOR
Intervention: Bony roof and cartilage roof measurements according to the Graf method of hip ultrasonography.
Number of subjects: 210
Study: 33495203

Group type: EXPERIMENTAL
Intervention: predictD‐intervention
Number of subjects: 2998

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 2998
Study: 34375323

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation (Intervention Group) for 12 months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine nutritional support (Control Group) for 12 months
Number of subjects: 80
Study: 33008427

Group type: EXPERIMENTAL
Intervention: Ixazomib in combination with cyclophosphamide and dexamethasone (ICD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclophosphamide and dexamethasone (CD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Switch from CD to ICD treatment
Number of subjects: 0
Study: 33158369

Group type: EXPERIMENTAL
Intervention: FeNO group (alter ICS based on FeNO and LABA based on symptoms)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group (alter treatment based on symptoms)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: ICS step-down
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: ICS step-up
Number of subjects: 220
Study: 34137783

Group type: EXPERIMENTAL
Intervention: Chemoendocrine therapy
Number of subjects: 954

Group type: EXPERIMENTAL
Intervention: Age > 40 years
Number of subjects: 954

Group type: COMPARATOR
Intervention: History of depression
Number of subjects: 954

Group type: COMPARATOR
Intervention: Worse physical well-being
Number of subjects: 954

Group type: COMPARATOR
Intervention: Worse social well-being
Number of subjects: 954

Group type: COMPARATOR
Intervention: Antidepressant use at study baseline
Number of subjects: 954
Study: 32553996

Group type: EXPERIMENTAL
Intervention: Nurse-led lifestyle intervention program
Number of subjects: 173

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 173
Study: 32482641

Group type: EXPERIMENTAL
Intervention: ePN (45 min enhanced partner notification communication skills counselling and the offer of provider‐assisted referral)
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: RR (45 min risk reduction skills counselling)
Number of subjects: 1050

Group type: COMPARATOR
Intervention: HE (20 min health education)
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: ePN
Number of subjects: 1050

Group type: COMPARATOR
Intervention: HE
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: RR
Number of subjects: 1050
Study: 34686091

Group type: EXPERIMENTAL
Intervention: Dynamic stratified potassium supplementation (intermittent infusions of 30 mmol/100 mL potassium chloride)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enteral potassium supplementation (10% potassium chloride administered orally in a bolus dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High intravenous potassium concentrations
Number of subjects: 0
Study: 32827526

Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training (home-based 45-minute sessions for 5-8 weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 60
Study: 35504555

Group type: EXPERIMENTAL
Intervention: Modafinil (400 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: COMPARATOR
Intervention: Caffeine
Number of subjects: 16
Study: 33901870

Group type: EXPERIMENTAL
Intervention: Avelumab plus axitinib
Number of subjects: 108

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 108
Study: 35025151

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Shenmen (HT 7) and Sanyinjiao (SP 6)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Shenmen (HT 7)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Electroacupuncture at Sanyinjiao (SP 6)
Number of subjects: 90
Study: 33260139

Group type: EXPERIMENTAL
Intervention: L-Arginine (6 g)
Number of subjects: 30
Study: 33166333

Group type: EXPERIMENTAL
Intervention: Group I (25OHD =20 ng/mL, vitamin D deficient)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Group II (>20 and <30 ng/mL, vitamin D insufficient)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Group III (25OHD =30 ng/mL, vitamin D sufficient)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Lower 25OHD levels
Number of subjects: 248
Study: 34752902

Group type: EXPERIMENTAL
Intervention: Aspirin plus placebo (n = 168)
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus placebo (n = 169)
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Aspirin plus clopidogrel (n = 168)
Number of subjects: 505

Group type: COMPARATOR
Intervention: Single antiplatelet therapy (SAPT)
Number of subjects: 505

Group type: COMPARATOR
Intervention: DAPT
Number of subjects: 505

Group type: COMPARATOR
Intervention: SAPT
Number of subjects: 505
Study: 34038856

Group type: EXPERIMENTAL
Intervention: iASSIST navigation system
Number of subjects: 83

Group type: COMPARATOR
Intervention: Conventional guide
Number of subjects: 83
Study: 35987554

Group type: EXPERIMENTAL
Intervention: Relaxation Therapy (RT)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Health Education Control
Number of subjects: 183
Study: 32839195

Group type: EXPERIMENTAL
Intervention: Postangiography plasma kidney injury molecule‐1
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: Postangiography plasma IL‐18
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: Absolute changes in plasma IL‐18
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: Relative ratios of plasma IL‐18
Number of subjects: 922

Group type: COMPARATOR
Intervention: Contrast‐associated AKI
Number of subjects: 922

Group type: COMPARATOR
Intervention: 90-day major adverse kidney events and death
Number of subjects: 922
Study: 34015475

Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil
Number of subjects: 8256

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8256
Study: 32434204

Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg upon admission followed by 40 mg/day)
Number of subjects: 709

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (40 mg upon admission followed by 20 mg/day)
Number of subjects: 709

Group type: EXPERIMENTAL
Intervention: Atorvastatin and Rosuvastatin
Number of subjects: 709
Study: 35513735

Group type: EXPERIMENTAL
Intervention: Adjuvant whole-brain radiotherapy (WBRT)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Observation (no WBRT)
Number of subjects: 89
Study: 33158826

Group type: EXPERIMENTAL
Intervention: Preference-informed, heterogeneity-focused HIV counselling and testing (HCT) offer with common and targeted options.
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Preference-informed, heterogeneity-focused HIV counselling and testing (HCT) offer with common and enhanced options.
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Common option and three predicted 'less preferred' options (active control arm).
Number of subjects: 1200
Study: 35943822

Group type: EXPERIMENTAL
Intervention: Itraconazole monotherapy
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combined itraconazole/isotretinoin therapy
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Voriconazole monotherapy
Number of subjects: 90
Study: 33733564

Group type: EXPERIMENTAL
Intervention: Genetic liability to bipolar disorder
Number of subjects: 0

Group type: COMPARATOR
Intervention: Genetic liability to lifetime cannabis use
Number of subjects: 0
Study: 32349752

Group type: EXPERIMENTAL
Intervention: Abstract interface (Kinect)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Concrete interface (Touchscreen)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Both groups (CP and control)
Number of subjects: 28
Study: 35942462

Group type: EXPERIMENTAL
Intervention: Total knee prosthesis (study group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Simple knee prosthesis (control group)
Number of subjects: 80
Study: 34994118

Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite at 22°C
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite at 4°C
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite at 37°C
Number of subjects: 45
Study: 32735335

Group type: EXPERIMENTAL
Intervention: Acceptance and commitment therapy-based group therapy program called Take a Breath, delivered via online videoconferences over 8 weeks (6 sessions).
Number of subjects: 313

Group type: COMPARATOR
Intervention: Waiting list control group receiving treatment as usual, offered the intervention 3 months after randomization.
Number of subjects: 313
Study: 32296925

Group type: EXPERIMENTAL
Intervention: Anterior SWL through anterior belly wall in supine position with countertraction
Number of subjects: 100

Group type: COMPARATOR
Intervention: Posterior SWL (standard approach)
Number of subjects: 100
Study: 35094679

Group type: EXPERIMENTAL
Intervention: Allogeneic bone grafting material
Number of subjects: 35

Group type: COMPARATOR
Intervention: Autologous bone grafts
Number of subjects: 35